BIOMAT Database Logo BIOMAT Database Logo

A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies. 2001

Robert W Shafer, and Kathryn Dupnik, and Mark A Winters, and Susan H Eshleman
Division of Infectious Diseases, Stanford University, Stanford, CA 94305.

UI MeSH Term Description Entries

Related Publications

Robert W Shafer, and Kathryn Dupnik, and Mark A Winters, and Susan H Eshleman
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.
January 2007, AIDS (London, England),
Robert W Shafer, and Kathryn Dupnik, and Mark A Winters, and Susan H Eshleman
Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase.
February 2008, AIDS (London, England),
Robert W Shafer, and Kathryn Dupnik, and Mark A Winters, and Susan H Eshleman
Sequence and structure based models of HIV-1 protease and reverse transcriptase drug resistance.
January 2013, BMC genomics,
Robert W Shafer, and Kathryn Dupnik, and Mark A Winters, and Susan H Eshleman
Nucleoside drug resistance in HIV-1 reverse transcriptase.
March 1995, Nature structural biology,
Robert W Shafer, and Kathryn Dupnik, and Mark A Winters, and Susan H Eshleman
MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors.
August 2019, Viruses,
Robert W Shafer, and Kathryn Dupnik, and Mark A Winters, and Susan H Eshleman
HIV-1 reverse transcriptase and antiviral drug resistance. Part 1.
April 2013, Current opinion in virology,
Robert W Shafer, and Kathryn Dupnik, and Mark A Winters, and Susan H Eshleman
The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.
January 2000, AIDS reviews,
Robert W Shafer, and Kathryn Dupnik, and Mark A Winters, and Susan H Eshleman
HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.
January 2020, PloS one,
Robert W Shafer, and Kathryn Dupnik, and Mark A Winters, and Susan H Eshleman
Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings.
February 2023, AIDS research and therapy,
Robert W Shafer, and Kathryn Dupnik, and Mark A Winters, and Susan H Eshleman
HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms.
May 2003, Journal of acquired immune deficiency syndromes (1999),
Copied contents to your clipboard!